Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 70,382 | 66,551 | 64,453 | 61,046 | 64,232 |
| Cost of Goods | 19,618 | 18,155 | 18,263 | 15,091 | 19,258 |
| Gross Profit | 50,764 | 48,396 | 46,190 | 45,955 | 44,974 |
| Operating Expenses | 30,983 | 30,776 | 27,621 | 25,734 | 29,090 |
| Operating Income | 20,399 | 17,775 | 18,832 | 20,312 | 16,142 |
| Interest Expense | 1,302 | 1,300 | 1,298 | 1,297 | 1,299 |
| Other Income | 3,092 | 3,197 | 2,766 | 3,558 | 3,227 |
| Pre-tax Income | 22,189 | 19,672 | 20,300 | 22,573 | 18,070 |
| Income Tax | 5,139 | 3,993 | 4,718 | 5,211 | 4,291 |
| Net Income Continuous | 17,050 | 15,679 | 15,582 | 17,362 | 13,779 |
| Net Income | $17,050 | $15,679 | $15,582 | $17,362 | $13,779 |
| EPS Basic Total Ops | 0.75 | 0.69 | 0.68 | 0.77 | 0.61 |
| EPS Basic Continuous Ops | 0.75 | 0.69 | 0.69 | 0.77 | 0.61 |
| EPS Diluted Total Ops | 0.74 | 0.68 | 0.69 | 0.75 | 0.60 |
| EPS Diluted Continuous Ops | 0.70 | 0.68 | 0.72 | 0.71 | 0.60 |
| EPS Diluted Before Non-Recurring Items | 0.74 | 0.68 | 0.68 | 0.62 | 0.60 |
| EBITDA(a) | $23,285 | $20,620 | $21,657 | $23,145 | $19,011 |